Max Healthcare share price: Analyst upgrades stock to buy, sees 18% upside

Share it

UBS expects the company to generate ₹8,000 crore in OCF over FY25-28, which will help fund its capacity expansion.

Leave a Comment

Your email address will not be published. Required fields are marked *